Association of Biotechnology Led Enterprises

News

Biocon Biologics excited about 2026 on biosimilars front

Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes.

Jan 06, 2026

By : Team ABLE

BioFunding News

Dec 31, 2025

By : Team ABLE

Ethanol blending hits 20 per cent in November 2025

Currently, India’s total ethanol production capacity as of November 2025 is about 1,990 crore litres, and the industry is calling for an increase in ethanol blending beyond 20 per cent, stating that capacities are underutilised.

Dec 20, 2025

By : Team ABLE

Lupin gets Positive CHMP Opinion for Biosimilar Ranibizumab

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A (VEGF-A).

Dec 18, 2025

By : Team ABLE

Lupin Receives Approval from US FDA for Biosimilar Armlupeg

Pegfilgrastim 6 mg/0.6 mL injection for subcutaneous use in a single-dose prefilled syringe had estimated annual sales of $ 1.3 billion in the U.S. for the 12 months ending September 2025.

Dec 12, 2025

By : Team ABLE